ABOUT COMPANY

Corporate Profile

Towards Better Healthcare…

Wanbury Limited, one of India’s fastest growing pharmaceutical companies amongst the ‘Top 50 Companies’ in India (as per ORG-IMS), has a strong presence in API global market and domestic branded Formulation. Wanbury’s major thrust area lies in Active Pharmaceutical Ingredient (API) sale in over 70 countries and Pan-India Formulation presence.

Active Pharmaceutical Ingredient :Wanbury has a basket of over 13 API products.

It is the largest manufacturer of Metformin with over 8500 tons per year.

It is the largest exporter of Tramadol to the US market.

Wanbury exports to over 50 countries, 65% of which comprises of regulated markets.

Has two US-FDA approved multi-product API facilities and one plant under operation for semi-regulatedmarkets.

Has been the preferred supplier to some of the top five generic players of the world.

Formulations :Pan-India presence in ethical formulations with a portfolio of close to 70 brands.

Strong presence in gynecology, orthopedics, heamatinics, anti-diabetic, neutraceuticals, gastro intestinal, stroke surgery, antibiotics, cough and cold solutions, anti-inflammatory, analgesics and general practitioner.

2012: API breaks records

* Wanbury API hits Rs 200crore annual mark and Rs 25crore/month mark

2008: Inaugurates CRAMS office in Zurich

2007: Year of Mergers

* Wanbury entered into a strategic association with Bravo Healthcare Limited

*Wanbury incorporated Ningxia Wanbury Fine Chemicals Co. Limited to source raw materials from China

*Wanbury approved as preferred vendor by Pfizer (U.S.) for Contract Research and Manufacturing Services (CRAMS)

* Cpink awarded ‘Best Brand Launch’ by ORG-IMS; did sales of Rs 11 crore

*ORG-IMS declared Wanbury Limited as the fastest growing company among top 100 companies in India

2006: Largest producer of MetforminWanbury Limited achieved 100 crore turnoverPharmaceutical Products of India Limited (PPIL) merged with Wanbury Limited pursuant to BIFR orderWanbury acquired Cantabria Pharma S.L. with presence in ethical branded formulations in the Spanish marketWanbury crossed 1000 employees markWanbury became the world’s largest producer of Metformin with production of 4,500 MT

2005: Acquires US-FDA approved facilitiesWanbury acquired Doctor’s Organics and Chemicals Limited, having a US-FDA approved facility for manufacturing multi-product API’s

2004: Wander to WanburyWander merged with Pearl Organics Limited and Pearl Organics Limited renamed as Wanbury Limited

Wanbury set up its R&D center in Navi Mumbai for API

Wanbury started using SAP as a business transaction system

2002: US-FDA for Patalganga plantPearl Organics Limited got US-FDA approval for Patalganga plant

1996: API Market in U.S.Pearl Organics Limited entered into a strategic alliance with Wyckoff Chemicals (US) to market its API in US

1995: Acquires Brij ChemicalsPearl Organics Limited acquired plant of Brij Chemicals Pvt. Limited at Patalganga (Maharashtra)

1992: Its first plant

*Pearl Organics Limited established its first plant in Tarapur for manufacturing API’s

1991: Going Public

*Pearl Distributors Pvt. Limited went public and was renamed as Pearl Organics Limited

1990: The journey begins

*Incorporated as Pearl Distributors Pvt. Limited

MissionWe, at Wanbury, want to build a company that people are proud of and committed to; where all employees have an opportunity to contribute, learn, grow, and advance on merits

We will continue to build a business model which is sustainable, growth-oriented and profitable.

We will worship exceptional and superior performance, concentrating on high-quality training and development.

We will continuously challenge status-quo/maintenance and simultaneously encourage and recognize stretch and growth

We will work hard not only to satisfy but delight our customers, thereby surpassing their expectations.

We will strive to make Wanbury one of the preferred employers.

VisionTo keep improving the quality of life by offering value added novel products that are

technologically innovative, cost-effective and of superior quality, surpassing expectations of customers across the globe

To have a $1 billion market cap

To be the fastest growing pharma company in India

ValuesRespect for people

* Valuing diversity

* Developing trust and openness

* Focusing on listening and feedback

* Treating people with respect and dignity

Innovation

* New ideas

* Unconventional thinking

* Risk taking

* Right to make mistakes

Sense of urgency

* Focusing on priorities and value-adding tasks

* Speed of action

* Fighting bureaucracy

* Delivering

Result focus

* Taking on challenging goals

* Meeting commitments and delivering quality results

* Adhering to set objectives and standards

* Measuring performance at regular periods

Leadership

* Motivating and energizing others

* Leading by example

* Acting in accordance with company vision & values

* Maintain high personal work standards

Teamwork

*  Cooperating and collaborating with colleagues

*   Encouraging and supporting colleagues to achieve goals

*   Focusing on both team and individual goals

*   Creating partnerships and using skills of others to excel in performance

Customer focus

*   Understanding the changing needs and expectations of customers

*   Delighting both internal and external customers

*   Adjusting service based on customer feedback thereby surpassing customers expectations

*   Take personal responsibility for serving customers

At Wanbury, Leadership is divided into two groups:

Focusing on annual budgets and short term objectives by the leadership team known as ‘Executive Team’ headed by the Managing Director..

Focusing on medium and long-term objectives such as vision, strategy, fund raising etc., carried out by the leadership team known as ‘Corporate Team’ headed by the Chairman’s office.

Linking and converting the strategy/vision with the financial goals is carried out by the task force headed by the MD.

The values followed by our leaders are:

Profit Enhancement Program (PEP): PEP programs are carried out every year to improve profits, figuring out alternative routes of manufacturing products, reducing cycle times, increasing per capita productivity per person, increasing per capita per liter output, cost reduction, wastages etc. is continuously carried out by separate task force in consultation with R&D along with SBUs, Divisions, and plant heads.

Innovation/problem solving: Is continuously encouraged in Wanbury by MECE principle (Mutually Exclusive and Collectively Exhaustive) where individual ideas as well as collective wisdom are encouraged continuously for better solutions and innovations.

Challenge your boss/CEO: Is one of the concepts being introduced very shortly in order to encourage frank and honest feedback from the subordinates/peers in the areas of styles of leadership, policies etc. thereby getting an opportunity for better performance.

At Wanbury, the corporate philosophy to support social causes is followed to the word. Wanbury has taken up various initiatives like:

National Eclampsia Registry -The FOGSI – ICOG initiative:

Wanbury supported a noble cause – National Eclampsia Registry – project initiated by FOGSI & ICOG. Eclampsia is hypertension during pregnancy, which leads to convulsions and may lead to the death of the mother as well as the child. The National Eclampsia Registry, the FOGSI-ICOG outfit, is the outcome of this need. Eclampsia and PET are identified as major contributors to maternal death. Around 10% of women develop PIH or pre-eclampsia (figures are much higher in India but we do not know). The later is particularly serious and can be fatal. The causes of pre-eclampsia are unknown but it can be identified and culmination into eclampsia, a seriously debilitating consequence can be prevented.

Wanbury provided the platform to more than 20,000 Gynaec doctors all over India to discuss issues related to Eclampsia.

Mankhurd’s Children Home:

Mankhurd’s children home is an orphanage, which consists of around 500 girls and boys who are physically and mentally challenged.

Wanbury supports the orphanage by regularly providing medicines to the children.

Telemedicine:

Telemedicine is the use of electronic communications and information technologies to provide clinical services when participants are at different locations. This term is often used to encompass a broader application of technologies to distance education, consumer outreach, and other applications wherein electronic communications and information technologies are used to support healthcare services. Videoconferencing, transmission of still images, e-health including patient portals, remote monitoring of vital signs, continuing medical education and nursing call centers are all considered part of telemedicine.

Wanbury initiated telemedicine with a motto to improve patient care, enhance medical training, standardize clinical practice, stabilize costs and unite clinicians worldwide.

Following are the timings when doctors will be available: Tuesday and Friday – 3 to 5p.mPhone no – 91-22-67942222If you have a web-cam, video conferencing can be done. Please call in case you need assistance for the same.

Wanbury InfoTech Pvt. Ltd. provides SAP consulting, software consulting, and infrastructure solution services; it has a dynamic team having expertise and experience in various industry

verticals. Currently, Wanbury InfoTech provides software consulting, infrastructure management services and Products to Wanbury Limited.

It offers the following services:

Website: Support, maintenance and upgradation, other facilitation like providing data to doctors, patients about our products.

IT solutions: Service provider – support, maintain, upgradation, implementation, roll-out, facilitation, training (SAP and other software), process improvements (through software implementation for better control of various departmental processes), and provide various controlling reports and business intelligence data for the top management to monitor the current performance and to plan for the future.

Wanbury InfoTech also provides leased circuits and internet services for running Wanbury Infrastructure, which connects various offices, factories and other locations of Wanbury Limited. It includes coordination between service providers for lease lines, negotiating annual fees and preparation of SLA (service level agreement with regards to uptime) and managing the servers, back-up devices, firewalls, routers and switches for smooth, secured and efficient functioning of Wanbury Network, and to ensure the protection and safety of Wanbury Data.

Support, maintenance, upgradation, facilitation and replacements of servers used for data storage and backup, SQL server, Linux server, and Tandberg backup device. In line with the company’s growth, Wanbury InfoTech plans the replacement of servers for various applications to provide the latest technology which can sustain and help the growth of the organization.

Computerized data for back office operations (telephone and email): Provides services and plans for the cost effective up gradation keeping in mind the latest trends in technology so that Wanbury users will benefit from it.

Support and maintain the videoconferencing equipment on call basis and as per requirement.

Plans the purchase of new hardware’s/software’s – Laptops, desktops, printers, servers, mobile internet cards to give latest technology benefit for Wanbury users. Also, Wanbury InfoTech continuously evaluates new software & technologies and proposes/implements the same in cost effective manner for improving efficiency.

Identifies/Evaluates/proposes/implements new and additional infrastructure in a cost effective manner to improve efficiency

Negotiates, maintains and monitors service level agreements with various service providers. Provides onsite and offshore consulting and support to clients and internal documentation for Wanbury users for the processes through software’s.

Financial Report

Wanbury is the largest manufacturer of some of its products like Metformin, Tramadol and Salsalate for the US market. Wanbury caters to more than 50% of the US market in these products and exports to over 50 countries, 65% of which comprise regulated markets. Wanbury has three manufacturing facilities including two US-FDA approved multi-product facilities. Wanbury maintains its leadership position by taking initiatives like ‘margin improvements including process alterations’, ‘backward integration’ and ‘long term supply chain management’.

Wanbury’s clients are some of the leading global generic players including Apotex, Teva, Mylan, McNeil etc.

Wanbury has filed over 27 DMFs and has two approved product patents to its credit namely Sertraline Hydrochloride and Carvedilol. Wanbury has applied for five product patents and one process patent and has a basket of over 23 API products.

Main Products:

Products CategoryMetformin Anti diabetic

Metformin DC

Tramadol Anti Analgesic

Sertraline Anti depressant

Diphenhydramine Hcl Anti Histaminic

Diphenhydramine Citrate Anti Histaminic

Mefenamic Acid Anti Inflammatory

Paroxetine Hemihydrate Anti depressant

Promethazine Anti Histaminic

Glucosamine Anti Arthritis

Clopidogrel Anti Thrombotic

Levitiracetam Anti epileptic

Carvedilol Phosphate Monohydrate Anti hypertensive

APIs : Intermediates

List of Intermediates that can be delivered at LAB & Plant scale

No. API Commercialized

1. Metformin HCL

2. Metformin HCL DC Grade 90%

3. Metformin HCL DC Grade 95%

4. Metformin HCL DC Grade 70%

5. Tramadol Hydrochloride

6.Sertraline Hydrochloride (Form I and Form II)

7. Diphenhydramine Hydrochloride

8. Diphenhydramine Citrate

9. Promethazine Hydrochloride

10. Mefenamic Acid

11. Glucosamine HCL

12. Glucosamine Sulfate Potassium Chloride

13. Glucosamine Sulfate Sodium Chloride

14. Methoxsalen

15. Paroxetine Hydrochloride Hemihydrate

16. Carvedilol Phosphate Monohydrate

API under scale up

ProductsGabapentin

Valaciclovir

Levetiracetam

Clopidogrel bisulfate

Promethazine Hydrochloride

API under development

ProductsQuetiapine

Ranolazine

Imiquimod

Rivaroxaban

Dabigatran

Salient features of Wanbury API Manufacturing

Closed product handling system from Dryer to final packing using PTS(Powder transfer system) for 2 major products Metformin & Tramadol

Pusher centrifuge in closed system Dedicated equipment stream for Metformin HCl, Tramadol HCl ISO Class-8 clean rooms for final processing

Reaction Capabilities :In addition to General reactions, Wanbury is specialized in the following reactions.

Products

Azidation

Bromination

Cyanation

Chiral Chemistry

Optical resolution

Demethylation

Grignard reaction

Sodium metal reactions

Metal hydride reductions

Friedel-Crafts Reactions

Nitration

n-Butyl Lithium Reactions

Reductions

High Pressure Reactions

Hydrogenation

High Temperature Reactions (250°C)

High Vacuum Distillations

Low temperature reactions (-80°C)

Tanuku PlantAnother US FDA Approved plant, is located at Tanuku in Andhra Pradesh. It is located 415 kms from Hyderabad. It is spread over an area of 18 acres.

       

 

Patalganga PlantUS FDA approved plant is located at Kaire Village, Taluka: Khalapur, District: Raigad, Maharashtra State. It is situated in Maharashtra Industrial Development Corporation (MIDC), a Govt. notified industrial park for chemical manufacturing. The site is located 80 kilometers south of Mumbai International Airport and is easily accessible by road.

       

 

Tarapur Plant

The plant is located at Tarapur, about 150 Kms. from Mumbai.

Address :Tanuku Plant: K. Illindalaparru - 534217 Iragavaram Manadal W.G.Dist., (AP) 

PATALGANGA Plant A-15, MIDC Industrial Area, Patalganga, Dist–Raigad-410 220 Maharashtra (India). 

 TARAPUR Plant N-24/25, MIDC, Tarapur, Dist-Thane.401506  

Home   Formulations

Wanbury, the fastest growing pharmaceutical company in India and amongst the top 100 companies as per ORG-IMS, has moved up from 118th rank in 2006 to 83rd in 2007, 64th rank in April 2008, 54th in September 2008 to 47th rank in January 2009 as per ORG-IMS. The formulation business continues to grow aggressively with new brand launches and new divisions being added to the business. .

Wanbury’s Domestic Formulations has strong presence in Gynaecology, Orthopedics, Surgery and Gastro-intestinal catering to more than 70,000 doctors.

We take great pride in our ability to provide innovative solutions. Over the past few years, we have launched 25 innovative products (including extensions) that were launched for the first time in India by Wanbury. Our pipeline is very strong and we are poised to launch over 50 innovative products over the next couple of years.

One of the key brands, Cpink, launched by Wanbury was awarded ‘Best Brand Launch’ by ORG-IMS in India in 2006-2007. Another key brand Rabiplus was awarded ‘Best Brand launch’ by ORG-IMS in India in 2007-2008. Similarly, Wanbury has carried out some more promising new brand launches each of which, registered sales in excess of Rs 10 crore in the launch year. Over the last couple of years, Wanbury has managed to get 4 of its products viz. Cpink, Rabiplus, Folinine and Adtrol Plus in the ‘Top 4’ brands in its respective segments.

Wanbury has four divisions namely Main division, Osteolife, Surglife and WOW catering to general doctors, orthopedic doctors, surgeons and gynecologists, respectively.

Wanbury Divisions

More.. More..

More.. More..

Home   Formulations   Innovations

We take great pride in our ability to provide innovative solutions. Over the past few years, we have launched 25 innovative products (including extensions) that were launched for the first time in India. Our pipeline is strong and we are poised to launch 50 more innovative products over the next couple of years.

Main Products:

Products Innovation

Cpink 50mg tablet(First to launch in India)

Ferrous ascorbate is known as the world’s reference iron due to its high bio-availability, which is much higher than other conventional irons. It also has reduced gastro-intestinal side-effects which otherwise are very common. Ferrous ascorbate containing 50 mg elemental iron was a novel concept as most other irons had 100 mg. Wanbury has also got a patent for the same.

Rabiplus capsule (First to launch in India)

Wanbury was the first to launch rabeprazole in pellet form with optimally stabilized tri-layer enteric coating. The pellet form offers much higher bio-availability, faster action and reduced inter-subject variability as compared to the tablet form. All other proton pump inhibitors (PPI) in the market were

essentially in tablet form with single layer enteric coating.

Cdense tablets, gems(First to launch in India)

This contains calcium orotate which is a mineral transporter. Wanbury was first to launch it in Indian market. The amount of elemental calcium absorbed from this salt is highest (95%) amongst all the available calciums. It directly deposits calcium within the osteoblast which is unlike traditional calciums.

Adtrol-Plus soft gelatin capsule (First to launch in India)

Most other anti-osteoporotic formulations contain only calcium and vit D3. Because of methylcobalamin, pyridoxine, folic acid; Adtrol Plus treats hyperhomocysteinemia which is an independent causal factor for osteoporosis. Wanbury was first to launch this concept in the Indian market. Other companies have followed this combination after it became highly successful for Wanbury.

Folinine softule(First to launch in India)

Wanbury was first to launch this combination in Indian market. Till then, either plain folic acid or folic acid with sub-optimal dose of methylcobalamin (500 or 750 microgram) brands were present. They were recommended only during first trimester of pregnancy. Wanbury launched the concept of hyperhomocysteinemia being an independent causal factor for pregnancy complication and proposed usage of this formulation for all 9 months which was a unique and highly successful concept.

Productiv - M (First to launch in India) Wanbury was the first to launch a combi-pack containing 25 tablets of Clomifene (25 mg) and 30 tablets of antioxidants, Multivitamins, Amino acids & Minerals combination. In the Indian market, only Clomifene tablets were available and multivitamins, mineral tablets were available separately. Wanbury was the first to launch the above combi-pack with a novel concept of synergy between different ingredients for better management of male infertility.

Productiv - F (First to launch in India) Wanbury was the first to launch the novel formula of Productiv-F which contained novel ingredients like chasteberry standardized extract, green tea standardized extract with proven role in treatment

of female infertility. In fact, the entire formula was the first of its kind in being evidence-based as high pregnancy rate has been observed with it in clinical studies. Otherwise, in Indian market, multivitamin mineral formulations are available but with no evidence documenting its success.

Cheer capsule(First to launch in India)

Indian market is flooded with water-soluble as well as fat-soluble multivitamin and multi-mineral preparations which are often prescribed after surgery to overcome post surgical convalescence. Also such formulations are prescribed to diabetic and CVD patients and to patients recovering from fever and infection. With Cheer capsule, Wanbury introduced a new concept of essential amino acids combined with water-soluble multivitamins and minerals. The reason for the same was that essential amino acids are building blocks for new cell formation which is required in above mentioned indications. Also the product was free from fat-soluble vitamins which have a risk of hypervitaminosis as these formulations are given empirically.

Cheer syrup (First to launch in India) Indian market is flooded with water-soluble as well as fat-soluble multivitamin preparations which are often prescribed after surgery to overcome post surgical convalescence. Also such formulations are prescribed to diabetic and CVD patients and to patients recovering from fever and infection. With Cheer syrup, Wanbury introduced a new concept of essential amino acids combined with water-soluble multivitamins. The reason for the same was that essential amino acids are building blocks for new cell formation which is required in above mentioned indications. Also the product was free from fat-soluble vitamins which have a risk of hypervitaminosis as these formulations are given empirically.

Following are the Highlight News of Wanbury:

23rd Annual Report 2010-2011

Postal Ballot Notice

Postal Ballot Form

Board Meeting - 30th May, 2011

Board Meeting - 2nd February, 2011

Resignation - Mr. Ashok Shinkar

Outcome of Board Meeting held on 29th October, 2010

Resignation - Mr. K. R. N. Moorthy

22nd Annual Report 2009-2010

Resignation - Mr. K. R. N. MoorthyNews Room :

International Quality Summit Award May 25 - 26, 2008.[26 March, 2008]

Wanbury FCCB subscribed by Deutsche Bank [07 Jan, 2008]

Wanbury Acquires Spain-based Cantabria for Euros 42 mn (Rupees 250 crore)

USFDA approved FacilityUnfinished facility built for US 5 times present capacity Proximity to existing facility

Coumara RadjaSenior Vice President - API Global Business Development & Marketing at Wanbury

Mumbai Area, India

Pharmaceuticals

Current Lupin Ltd.

Previou

s

Calyx Chemicals & Pharmaceuticals Ltd. , Micro Inks Ltd ,Hostmann-Steinberg USA (earlier known as Micro Inks Corporation)

Educati

on Indian Institute of Management, Ahmedabad

SUMMARY

International Experience – Corporate Strategy, Communications, Marketing, Sales and Business Development - Enterprise value creation –Start-ups – Turnaround –Growth - Education and Teaching.

Entrepreneurial professional with over 20 years experience with demonstrated success providing strategic and marketing leadership. Lived in the US for over five years and travelled extensively across 60 countries for business. Track record of building winning teams in uncertain start-up environment, growth and turnaround situations in different industries including Life Sciences/Pharma and playing different

roles.

Established global businesses with clear focus on Market development and extension. Talented in proactively identifying opportunities/problems, putting together strategic initiatives, capable of resolving issues across multiple functions. Corporate positioning, Knowledge management, strengthening and leveraging Brand Equity and directing workflow for efficient information system and enhancing stakeholders’ value.Prior to joining the Bilakhia group worked with established business houses like Atul and Godrej. 

Has a Masters in Science and has two Masters in Business Management degrees including an M.B.A from the premier International Management Institute (IMI), New Delhi and a gold medallist in MIM (Masters in International Marketing) from Indian Institution of Export and Import Management (IIEIM), Mumbai. A crash couse in Indian Institute of Management, Ahmedabad (IIM A) on Strategy and Marketing and wrote case studies for management students at IIM A.

Presently working with Wanbury, a Pharma company, at Corporate Office as Senior Vice President - API Global Business Development & Marketing. Earlier, for five years, was with with Lupin Ltd as Head of Advanced Markets - API and CRAMS. And, till June 2008 was working with Calyx Chemicals & Pharmaceuticals Ltd. heading the API and guiding CRAMS Business as President – Corporate Strategy & International Business.

Specialties:Corporate Strategy, International Business, Branded sales, Corporate Communications, Human Resource Management, Taining, Mentoring and Coaching.

EXPERIENCE

Senior General Manager - International Business. Head API & CRAMS - Advanced Markets & Latin AmericaLupin Ltd.June 2008 – Present (4 years 10 months)Mumbai Area, India

Lupin is a 44-year old pharmaceutical transnational company manufacturing and marketing worldwide many Active Pharmaceutical Ingredients (APIs), Intermediates and Formulations. Lupin has offices/joint ventures in USA, Japan, Europe, Latin America, Africa and Australia. Ranks among Top Five in Pharmaceutical companies in India and the state-of-the-art manufacturing facilities across India and a unique Research park in Pune. One of the fastest growing Pharma majors in India.

Joined in June 2008 as Senior General Manager - International Business and Development for Latin American Region and Europe for APIs and Special Projects for identifying Nutraceuticals for further diversification.

Later on, the North American Business for APIs was entrusted and am involved in identifying NCE-1 molecules as strategic business growth with innovators and major global generic players.

Also, responsible for CRAMS and API intermediates.

President - Corporate StrategyCalyx Chemicals & Pharmaceuticals Ltd.April 2007 – June 2008 (1 year 3 months)

Calyx is a 28-year old pharmaceutical company manufacturing and marketing worldwide more than 20 Active Pharmaceutical Ingredients (APIs) and Intermediates and recenty diversified into Contract Research and Manufacturing Services (CRAMS), Full-Time Equivalent (FTE) Research. Has cGMP, WHO, US FDA approved manufacturing facilities in India and overseas offices and Business teams in USA, Japan and China.

The International Business Division caters to more than 45 countries and achieved significant business growth.

• As President – Corporate Strategy and International Business, responsible and accountable for steering strategic growth in Pharmaceutical Products and Services and in key countries for realizing the vision of achieving three fold growth in three years. 

• Explored and concluded various strategic options for capital mobilization for funding growth.

• Positioned the Brand Calyx through innovative initiatives and for gaining visibility.

• Spearheaded “Concept to Commercialization” of products.

Succeeded in exporting to fourteen more countries within a short span of one year and achieved 35% growth in direct exports in 2007-08 over the previous year.

• Reporting directly to the Chairman & Managing Director.

Head - International Business & Corporate CommunicationsMicro Inks LtdFebruary 2005 – March 2007 (2 years 2 months)

• As Head - International Business & Corporate Communications, responsible and accountable for steering strategic growth in key countries for increasing profitability, positioning the company with a quality reputation and exploring new avenues and product lines through a senior and middle management marketing, technical and customer support team.

• Overall responsibility for ensuring customer-centric approach and customer satisfaction in the complex and diversified-multicultural customer base.

• Leading, directing and managing the International Business team through training, coaching and constantly challenging their potential to sustain the competitive advantage.

• As Head of Corporate Communications - responsible for overall communication initiatives - conceptualized and implemented award winning corporate videos, Annual reports, website, advertisements, etc.

• Travelled to the BRIC countries /and some of the fastest developing countries like Brazil, Russia, Turkey, South Africa, and others: Argentina, Sudan, Germany, France, Netherlands, U.K.

• Reported directly to the Executive Director.

Vice President - Corporate AffairsHostmann-Steinberg USA (earlier known as Micro Inks Corporation)August 1999 – January 2005 (5 years 6 months)

Hostmann-Steinberg (earlier known as Micro Inks Corporation) is 100% Subsidiary of Micro Inks Ltd, India. Established in 2000 and in a short span of 3 years it emerged to rank #12 and grew to US$76 million in just five years and ranked #10 in North American Printing Ink industry

• As Vice President - Corporate Affairs and as Board Director - responsible for Corporate Finance & Accounts, Legal, Human Resources, Customer Services and Corporate Communications.

• Handpicked and empowered by the Chairman and the Founder of Micro Inks Ltd to establish the 100% Subsidiary in the U.S. So, started a green field operation - making things happen by setting up Corporate office, manufacturing facilities, recruited an able top and senior management team and mobilized US$35 million.

• Vision, Mission and Guiding Principles were conceptualized and inculcated into the minds of the people.

• Rolled out Corporate and HR policies and procedures, ISO 9000 and 14000.

• During the five year tenure kept the company out of litigations and employees out of strikes/protests.

• Conceptualized and worked through advertisement agencies for corporate advertisements, videos, presentations, website and won national and international awards.

• Implemented Score Cards, Performance Appraisal systems, Training and Development and recognized and rewarded the star employees.

• Won awards for business growth and community development and Quality Supplier award from the #1 Printer in the world.

• Reported directly to the President & CEO.

Head - International Business & Corporate CommunicationsMitsu Industries Ltd. (now Bayer Cropscience)April 1977 – August 1999 (22 years 5 months)

Mitsu Industries Ltd. (one of the divisions was acquired, in 1999, by Bayer CropScience, Germany) was #1 in Exports in 1999. Global scale manufacturing of highly complex chiral chemistry based high value agrochemical products.

• As International Business Head - steered strategic growth and planned for corporate excellence and helped identify new high value molecules.

Travelled to more than 30 countries - including U.K, Belgium, Germany, Russia, Turkey, Greece, Cyprus, Middle East, Israel, Jordan, Syria, Yemen, Egypt, Sudan, South Africa, S. Korea, Taiwan, Singapore, Hong Kong, and others.

• Travelled to China more than seven times in one year to establish business. Lived in China continuously for more than one month.

• Recognized for winning awards for company's export growth - company received seven prestigious awards in 1999

• Reported directly to the Executive DirectorBusiness HeadMitsu Industries Ltd, Vapi1997 – 1998 (1 year)

Head - SBU (Agrochemicals)Godrej Agrovet Ltd.April 1993 – March 1997 (4 years)

Godrej Agrovet Ltd (part of 110-year-old and reputed Godrej group) - revenues more than US$300 million - in the field of Vet and Agricultural products including Fresh farm vegetables and fruits.

• As Head of SBU - Agrochemicals - turned around the loss making unit to the second profitable unit in Godrej Agrovet in a matter of one year with a unique Business Model

• Led, directed and managed a National wide sales and Marketing team.

• Presented a blueprint for a sustained profitable growth with an innovative business model and was appreciated and approved instantly by Nadir Godrej, Chairman and Dr. Anaokar, M.D

• Triggered a new lease of hope and made it happen with a lean team in the initial phase and built up aggressively through creative brand management

• Other Agrochem companies pursued our benchmarks pertaining to sales force productivity, Debtor days, Working capital management, Brand rationalization, Innovative sales promotion schemes, Road shows, and team spirit.

• Part of the Corporate Planning team for the whole Godrej Group.

• Tracked national and international trends in the performance of various agrochem molecules and sourced effectively for ensuring a cost effective supply chain management.

• Helped the industry magazines cater to the real needs of the industry and was the Honorary Editor in Pestology and wrote management articles and reviewed business books.

• Reported directly to Managing Director.

EDUCATION

Indian Institute of Management, AhmedabadMDP, Strategy and Marketing1996 – 1996

Best Project and Presentation. Invited to write a Case Study for the IIM students and my Case Study was accepted and students benefitted from the case study.

Activities and Societies: Team Leader. Group Discussions. Interaction with the industry experts.Indian Institution of Export and Import Management, MumbaiMIM, International Marketing1994 – 1996

International Management Institute, New DelhiMBA, International Business1990 – 1991

TNAUB. Sc Ag & M.Sc Ag, Agricultural Science1979 – 1985

Petit Seminaire High SchoolMatriculation, English, maths, Physics, Chemistry1967 – 1978

ADDITIONAL INFO

1.Interestso English Classics - books and Films; Travelling - understanding and

appreciating different cultures across the globe; Collage; Mentoring; Teaching

2.Personal DetailsBirthday

February 23

HONORS & AWARDS

ICAR Fellowship - National MeritGold Medalist -Indian Institution of Export and Import Management

ORGANIZATIONS

Saumitra, Indian Institution of Export and Import Management, International Management Institute,TNAU, Petit Seminaire High School, Chicago Filmed Book Club